This Comment will consider several of the more common grounds justifying compulsory licenses, particularly as they affect international transactions. After analyzing the dynamic between each theory\u27s practical economic effect and general economic philosophy, the Comment will then question whether the current United States policy against general compulsory licenses remains viable in today\u27s economic markets
Wealthy countries with major pharmaceutical industries have historically supported strong patent rig...
Under the legal doctrine of first sale, or patent exhaustion, a patent holder's ability to license m...
A pharma manufacturer enters a developing country with a new drug after investing some R&D in th...
This Comment will consider several of the more common grounds justifying compulsory licenses, partic...
As technology continues to advance at a rapid pace, so do the number of patents that cover every asp...
Many advocates for using compulsory licensing ( CL ) for pharmaceutical patents in developing countr...
Patents provide monopoly rights to patent owners to manufacture, sell, and import the product result...
Patents provide monopoly rights to patent holders. There are safeguards in patent regime to ensure t...
This presentation explores renewed calls for compulsory licensing of pharmaceutical patents in the U...
In this Comment, the author traces the relevant legislative history pertaining to compulsory licensi...
In a stylized model involving two agents a developing country (called South) and a foreign patent-ho...
Efficient exploitation of a patent often requires patentees to license users of their inventions. Th...
76-81Ever since compulsory licensing has emerged as a statutory obligation, it has been debated aro...
We show the impact of technology licensing on optimal patent policy. Strong patent protection that e...
The patent system is built on the premise that patents provide an incentive for innovation by offeri...
Wealthy countries with major pharmaceutical industries have historically supported strong patent rig...
Under the legal doctrine of first sale, or patent exhaustion, a patent holder's ability to license m...
A pharma manufacturer enters a developing country with a new drug after investing some R&D in th...
This Comment will consider several of the more common grounds justifying compulsory licenses, partic...
As technology continues to advance at a rapid pace, so do the number of patents that cover every asp...
Many advocates for using compulsory licensing ( CL ) for pharmaceutical patents in developing countr...
Patents provide monopoly rights to patent owners to manufacture, sell, and import the product result...
Patents provide monopoly rights to patent holders. There are safeguards in patent regime to ensure t...
This presentation explores renewed calls for compulsory licensing of pharmaceutical patents in the U...
In this Comment, the author traces the relevant legislative history pertaining to compulsory licensi...
In a stylized model involving two agents a developing country (called South) and a foreign patent-ho...
Efficient exploitation of a patent often requires patentees to license users of their inventions. Th...
76-81Ever since compulsory licensing has emerged as a statutory obligation, it has been debated aro...
We show the impact of technology licensing on optimal patent policy. Strong patent protection that e...
The patent system is built on the premise that patents provide an incentive for innovation by offeri...
Wealthy countries with major pharmaceutical industries have historically supported strong patent rig...
Under the legal doctrine of first sale, or patent exhaustion, a patent holder's ability to license m...
A pharma manufacturer enters a developing country with a new drug after investing some R&D in th...